| Multiple Colorectal Adenomas, Classic Adenomatous Polyposis, and Germ-Line Mutations in MYH OM Sieber, L Lipton, M Crabtree, K Heinimann, P Fidalgo, RKS Phillips, ... New England Journal of Medicine 348 (9), 791-799, 2003 | 1116 | 2003 |
| The ‘just-right’ signaling model: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade C Albuquerque, C Breukel, R van der Luijt, P Fidalgo, P Lage, FJM Slors, ... Human molecular genetics 11 (13), 1549-1560, 2002 | 442 | 2002 |
| The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer P Watson, R Bützow, HT Lynch, JP Mecklin, HJ Järvinen, HFA Vasen, ... Gynecologic oncology 82 (2), 223-228, 2001 | 294 | 2001 |
| DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation M Cravo, P Fidalgo, AD Pereira, A Gouveia-Oliveira, P Chaves, J Selhub, ... European Journal of Cancer Prevention, 473-479, 1994 | 217 | 1994 |
| Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or “multiple” colorectal adenomas OM Sieber, H Lamlum, MD Crabtree, AJ Rowan, E Barclay, L Lipton, ... Proceedings of the National Academy of Sciences 99 (5), 2954-2958, 2002 | 179 | 2002 |
| Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma MA Rodriguez‐Bigas, HFA Vasen, HT Lynch, P Watson, T Myrhøj, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 171 | 1998 |
| Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis: randomized, double-blind, controlled trial A Pinto, P Fidalgo, M Cravo, J Midões, P Chaves, J Rosa, ... Diseases of the colon & rectum 42 (6), 788-795, 1999 | 147 | 1999 |
| Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. M Cravo, R Pinto, P Fidalgo, P Chaves, L Gloria, C Nobre-Leitao, FC Mira Gut 39 (3), 434-438, 1996 | 138 | 1996 |
| Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study P Lage, M Cravo, R Sousa, P Chaves, M Salazar, R Fonseca, I Claro, ... Official journal of the American College of Gastroenterology| ACG 99 (9 …, 2004 | 115 | 2004 |
| APC or MUTYH mutations account for the majority of clinically well‐characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas B Filipe, C Baltazar, C Albuquerque, S Fragoso, P Lage, I Vitoriano, ... Clinical genetics 76 (3), 242-255, 2009 | 73 | 2009 |
| Anti-Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: report of a case-control study J Estevens, P Fidalgo, T Tendeiro, C Chagas, A Ferra, CN Leitao, FC Mira European journal of cancer prevention 2 (5), 377-380, 1993 | 73 | 1993 |
| High prevalence of human papillomavirus in squamous cell carcinoma and matched normal esophageal mucosa. Assessment by polymerase chain reaction PO Fidalgo, ML Cravo, PP Chaves, CN Leitão, FC Mira Cancer 76 (9), 1522-1528, 1995 | 69 | 1995 |
| Risk of colorectal cancer associated with the C677T polymorphism in 5, 10-methylenetetrahydrofolate reductase in Portuguese patients depends on the intake of methyl-donor nutrients CS Guerreiro, B Carmona, S Gonçalves, E Carolino, P Fidalgo, M Brito, ... The American journal of clinical nutrition 88 (5), 1413-1418, 2008 | 68 | 2008 |
| BAT‐26 identifies sporadic colorectal cancers with mutator phenotype: a correlative study with clinico‐pathological features and mutations in mismatch repair genes M Cravo, P Lage, C Albuquerque, P Chaves, I Claro, T Gomes, C Gaspar, ... The Journal of Pathology 188 (3), 252-257, 1999 | 68 | 1999 |
| Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability C Albuquerque, C Baltazar, B Filipe, F Penha, T Pereira, R Smits, ... Genes, Chromosomes and Cancer 49 (8), 746-759, 2010 | 63 | 2010 |
| Detection of mutations in mismatch repair genes in Portuguese families with hereditary non-polyposis colorectal cancer (HNPCC) by a multi-method approach P Fidalgo, MR Almeida, S West, C Gaspar, L Maia, J Wijnen, ... European Journal of Human Genetics 8 (1), 49-53, 2000 | 55 | 2000 |
| Missense and nonsense mutations in codon 659 of MLH1 cause aberrant splicing of messenger RNA in HNPCC kindreds M Nyström‐Lahti, M Holmberg, P Fidalgo, R Salovaara, A De La Chapelle, ... Genes, Chromosomes and Cancer 26 (4), 372-375, 1999 | 51 | 1999 |
| The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation A Suspiro, P Fidalgo, M Cravo, C Albuquerque, E Ramalho, NC Leitão, ... Official journal of the American College of Gastroenterology| ACG 93 (9 …, 1998 | 50 | 1998 |
| Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing M Cravo, AJ Afonso, P Lage, C Albuquerque, L Maia, C Lacerda, ... Gut 50 (3), 405-412, 2002 | 44 | 2002 |
| Developments in zebrafish avatars as radiotherapy sensitivity reporters—towards personalized medicine B Costa, S Ferreira, V Póvoa, MJ Cardoso, S Vieira, J Stroom, P Fidalgo, ... EBioMedicine 51, 2020 | 42 | 2020 |
